FDA Issues GMP Warning to Bausch and Lomb, Indian API Maker
FDA Issues GMP Warning to Bausch and Lomb, Indian API Maker The U.S. Food and Drug Administration has issued a formal warning to eye‑care giant Bausch & Lomb and an Indian active‑pharmaceutical‑ingredient (API) supplier for alleged violations of Good Manufacturing Practice (GMP). The notice, released in September 2026, details specific deficiencies that could affect product safety and efficacy. … اقرأ المزيد